ArticleCPT: pharmacometrics & systems pharmacology2024

Modeling of HIV-1 prophylactic efficacy and toxicity with islatravir shows non-superiority for oral dosing, but promise as a subcutaneous implant.

Hee-Yeong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.